Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 28;9(1):3147.
doi: 10.1038/s41598-018-37431-8.

Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer's Disease

Collaborators, Affiliations

Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer's Disease

Azhaar Ashraf et al. Sci Rep. .

Erratum in

Abstract

Metal/mineral dyshomeostasis has been implicated in the development of Alzheimer's disease (AD). The aim of the study was to investigate the difference in absolute and percentage levels of plasma phosphorus, calcium, iron, zinc, copper, selenium in cognitively normal (CN) and AD subjects. Total reflection X-ray fluorescence (TXRF) spectroscopy was used to detect plasma metals/minerals in CN and AD subjects (n = 44 per group). TXRF detected significantly increased plasma levels of phosphorus (p = 1.33 × 10-12) and calcium (p = 0.025) in AD compared to CN subjects, with higher phosphorus/calcium (p = 2.55 × 10-14) ratio in the former. Percentage concentrations calculated for phosphorus, calcium, iron, zinc, copper, selenium by dividing the concentration of each element by the total concentration of these elements and multiplying by 100%, demonstrated phosphorus was higher in AD compared to CN subjects, while calcium, iron, zinc, copper and selenium were lower in AD subjects, with area under the curves as high as 0.937 (p = 6 × 10-5) computed from receiver operating curves. With exclusion of high levels of phosphorus and calcium from percentage calculations, iron levels remained low in AD whereas zinc was higher in AD, and copper and selenium levels were similar. We demonstrate altered distribution of elements in the plasma of AD subjects with high interdependencies between elemental levels and propose the potential of TXRF measurements for disease monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Dot plot of Total Reflectance X-Ray Fluorescence (TXRF) measurements of elements in plasma from cognitively normal (CN) and Alzheimer’s Disease (AD) subjects. P-values for each element and the phosphorus/calcium ratio are shown following normalisation of data and ANCOVA testing (see Table 1).
Figure 2
Figure 2
Heat map of partial correlations between the phosphorus, calcium, iron, copper, selenium and zinc (of the transformed data), controlling for age, sex, APOE status and diagnosis. (The correlation coefficient, r, is the top value in the matrix cell with the p-value below.) Phosphorus, copper and selenium have been square-root transformed, while calcium, iron and zinc were log-transformed.
Figure 3
Figure 3
Receiver operating curves (ROC) of binary logistic regression modelling of cognitively normal (CN) and Alzheimer’s Disease (AD) subjects. Base model includes age, sex, APOEε4 genotype (A) and addition of percentage phosphorus (B); calcium (C); iron (D), copper (E), selenium (F) and zinc (G), and phosphorus/calcium (H). AUC – Area under the curve.

References

    1. Jack CR, Jr., et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–216. doi: 10.1016/S1474-4422. - DOI - PMC - PubMed
    1. Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL. Homeostasis of metals in the progression of Alzheimer’s disease. Biometals. 2014;27:539–549. doi: 10.1007/s10534-014-9728-5. - DOI - PubMed
    1. Paglia G, et al. Distinctive Pattern of Serum Elements During the Progression of Alzheimer’s Disease. Sci Rep. 2016;6:22769. doi: 10.1038/srep22769. - DOI - PMC - PubMed
    1. Canzoniero LM, Snider BJ. Calcium in Alzheimer’s disease pathogenesis: too much, too little or in the wrong place? J Alzheimers Dis. 2005;8(147–154):209–115. - PubMed
    1. Gilli P, De Bastiani P. Cognitive function and regular dialysis treatment. Clin Nephrol. 1983;19:188–192. - PubMed

Publication types